Lupine Q4 Results: Firm Reports Consolidated PAT of ₹247 Crore, Declares Dividend

Pharma major Lupine posts consolidated net profit 246.7 crore in Q4 of FY23, which is attributable…

Strong domestic market set to boost fourth quarter of Indian drugmakers

According to analysts, Indian drugmakers have been able to overcome challenges in export markets, mainly the…

Day trading guide for today: 4 stocks to buy or sell on Monday, April 17

Day trading guide for today: After recovering from the morning selloff, the Indian stock market closed…

Stocks to watch: BPCL, NDTV, Adani Green, IRCTC, Vodafone Idea

BPCLBharat Petroleum Corporation Ltd., India’s second largest oil refining and fuel retailing firm, plans to expand…

Stocks to watch today: Wipro, Lupine, Tata Power, TVS Motor, and others

Stocks to watch on Thursday: nifty Futures on the Singapore Exchange were trading up 53 points,…

Lupine’s weak margins impact the stock in the fourth quarter

Shares of Lupine Ltd fell nearly 7% on the National Stock Exchange on Thursday. Investors are…

Lupine shares hit 52-week low on margin pressure, fall in earnings

The performance of Lupine Ltd for the quarter ended December failed to boost investor confidence. On…

Lupine acquires branded portfolio to boost domestic sales

The proposed acquisition of a portfolio of brands of Anglo-French Drugs & Industries and its associates…

Lupine gets relief from USFDA approval

Lupine Ltd has got relief this week. That’s because at least one of its many plants,…